AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARS Pharmaceuticals, Inc. Director's Dealing 2022

Nov 10, 2022

Director's Dealing

Opens in your device viewer

Issuer: ARS Pharmaceuticals, Inc. (SPRY)
CIK: 0001671858
Period of Report: 2022-11-08

Reporting Person: Lowenthal Richard E (Director, President and CEO, 10% Owner)